Zimmer Partners’s Neurocrine Biosciences NBIX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-63,000	Closed	-$8.3M	–	146
2023 Q4	$8.3M	Buy	63,000 +2,300	+4%	+$303K	0.3%	53
2023 Q3	$6.83M	Buy	60,700 +42,500	+234%	+$4.78M	0.18%	65
2023 Q2	$1.72M	Buy	+18,200	New	+$1.72M	0.04%	93